|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net Income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Impairment of property and equipment and right-of-use asset due to OVJP restructuring | |||||
| Amortization of intangibles | |||||
| Change in excess inventory reserve | |||||
| Investment gains, net | |||||
| Impairment of minority investments | |||||
| Stock-based compensation | |||||
| Stock-based compensation to Board of Directors and Scientific Advisory Board | |||||
| Deferred income tax benefit | |||||
| Retirement plan expense, net of benefit payments | |||||
| Decrease (increase) in assets: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Other current assets | |||||
| Other assets | |||||
| Increase (decrease) in liabilities: | |||||
| Accounts payable and accrued expenses | |||||
| Other current liabilities | |||||
| Deferred revenue | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Purchases of property and equipment | |||||
| Purchase of intangibles | |||||
| Purchases of investments | |||||
| Proceeds from sale and maturity of investments | |||||
| Net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Proceeds from issuance of common stock | |||||
| Repurchase of common stock | |||||
| Payment of withholding taxes related to stock-based compensation to employees | |||||
| Cash dividends paid | |||||
| Net cash used in financing activities | |||||
| INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | |||||
| CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR | |||||
| CASH AND CASH EQUIVALENTS, END OF YEAR | |||||
Loading...